Skip to main content
Top
Published in: Supportive Care in Cancer 7/2021

Open Access 01-07-2021 | Care | Original Article

Treatment goals and changes over time in older patients with non-curable cancer

Authors: M. E. Stegmann, D. Brandenbarg, A. K. L. Reyners, W. H. van Geffen, T. J. N. Hiltermann, A. J. Berendsen

Published in: Supportive Care in Cancer | Issue 7/2021

Login to get access

Abstract

Purpose

To investigate the treatment goals of older patients with non-curable cancer, whether those goals changed over time, and if so, what triggered those changes.

Methods

We performed a descriptive and qualitative analysis using the Outcome Prioritization Tool (OPT) to assess patient goals across four conversations with general practitioners (GPs) over 6 months. Text entries from electronic patient records (hospital and general practice) were then analyzed qualitatively for this period.

Results

Of the 29 included patients, 10 (34%) rated extending life and 9 (31%) rated maintaining independence as their most important goals. Patients in the last year before death (late phase) prioritized extending life less often (3 patients; 21%) than those in the early phase (7 patients; 47%). Goals changed for 16 patients during follow-up (12 in the late phase). Qualitative analysis revealed three themes that explained the baseline OPT scores (prioritizing a specific goal, rating a goal as unimportant, and treatment choices related to goals). Another three themes related to changes in OPT scores (symptoms, disease course, and life events) and stability of OPT scores (stable situation, disease-unrelated motivation, and stability despite symptoms).

Conclusion

Patients most often prioritized extending life as the most important goal. However, priorities differed in the late phase of the disease, leading to changed goals. Triggers for change related to both the disease (e.g., symptoms and course) and to other life events. We therefore recommend that goals should be discussed repeatedly, especially near the end of life.

Trial registration

OPTion study: NTR5419
Literature
7.
go back to reference Lynn J, Adamson DM (2003) Living well at the end of life: adapting health care to serious chronic illness in old age. Santa Monica: : CA: Rand Corporation Lynn J, Adamson DM (2003) Living well at the end of life: adapting health care to serious chronic illness in old age. Santa Monica: : CA: Rand Corporation
13.
go back to reference Malterud K (1993) Shared understanding of the qualitative research process. Guidelines for the medical researcher. Fam Pract 10:201–206CrossRef Malterud K (1993) Shared understanding of the qualitative research process. Guidelines for the medical researcher. Fam Pract 10:201–206CrossRef
14.
go back to reference Malterud K (2001) Qualitative research: standards, challenges, and guidelines. Lancet 358:483–488CrossRef Malterud K (2001) Qualitative research: standards, challenges, and guidelines. Lancet 358:483–488CrossRef
16.
go back to reference Moss AH, Lunney JR, Culp S, Auber M, Kurian S, Rogers J, Dower J, Abraham J (2010) Prognostic significance of the “surprise” question in cancer patients. J Palliat Med 13:837–840CrossRef Moss AH, Lunney JR, Culp S, Auber M, Kurian S, Rogers J, Dower J, Abraham J (2010) Prognostic significance of the “surprise” question in cancer patients. J Palliat Med 13:837–840CrossRef
17.
go back to reference Veldhoven CMM, Nutma N, De Graaf W et al (2019) Screening with the double surprise question to predict deterioration and death: an explorative study. BMC Palliat Care 18:118CrossRef Veldhoven CMM, Nutma N, De Graaf W et al (2019) Screening with the double surprise question to predict deterioration and death: an explorative study. BMC Palliat Care 18:118CrossRef
19.
go back to reference Rubin G, Berendsen A, Crawford SM, Dommett R, Earle C, Emery J, Fahey T, Grassi L, Grunfeld E, Gupta S, Hamilton W, Hiom S, Hunter D, Lyratzopoulos G, Macleod U, Mason R, Mitchell G, Neal RD, Peake M, Roland M, Seifert B, Sisler J, Sussman J, Taplin S, Vedsted P, Voruganti T, Walter F, Wardle J, Watson E, Weller D, Wender R, Whelan J, Whitlock J, Wilkinson C, de Wit N, Zimmermann C (2015) The expanding role of primary care in cancer control. Lancet Oncol 16:1231–1272. https://doi.org/10.1016/S1470-2045(15)00205-3CrossRefPubMed Rubin G, Berendsen A, Crawford SM, Dommett R, Earle C, Emery J, Fahey T, Grassi L, Grunfeld E, Gupta S, Hamilton W, Hiom S, Hunter D, Lyratzopoulos G, Macleod U, Mason R, Mitchell G, Neal RD, Peake M, Roland M, Seifert B, Sisler J, Sussman J, Taplin S, Vedsted P, Voruganti T, Walter F, Wardle J, Watson E, Weller D, Wender R, Whelan J, Whitlock J, Wilkinson C, de Wit N, Zimmermann C (2015) The expanding role of primary care in cancer control. Lancet Oncol 16:1231–1272. https://​doi.​org/​10.​1016/​S1470-2045(15)00205-3CrossRefPubMed
21.
go back to reference Noteboom EA, Perfors IAA, May A et al (2020) GP involvement after a cancer diagnosis; patients’ unmet need for decision support. Submitted Noteboom EA, Perfors IAA, May A et al (2020) GP involvement after a cancer diagnosis; patients’ unmet need for decision support. Submitted
Metadata
Title
Treatment goals and changes over time in older patients with non-curable cancer
Authors
M. E. Stegmann
D. Brandenbarg
A. K. L. Reyners
W. H. van Geffen
T. J. N. Hiltermann
A. J. Berendsen
Publication date
01-07-2021
Publisher
Springer Berlin Heidelberg
Keyword
Care
Published in
Supportive Care in Cancer / Issue 7/2021
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-020-05945-5

Other articles of this Issue 7/2021

Supportive Care in Cancer 7/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine